Literature DB >> 7518137

Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression.

J Reyes1, A G Tzakis, H Bonet, M Green, E Yunis, M Nalesnik, B Nour, S Kocoshis, K Abu-Elmagd, S Todo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7518137      PMCID： PMC2957121     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Opportunistic cancers in patients with immunodeficiency syndromes.

Authors:  D T Purtilo
Journal:  Arch Pathol Lab Med       Date:  1987-12       Impact factor: 5.534

2.  Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.

Authors:  J Reyes; A Tzakis; M Green; B Nour; M Nalesnik; D Van Thiel; M Martin; M K Breinig; J J Fung; M Cooper
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 3.  The diagnosis and treatment of posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; L Makowka; T E Starzl
Journal:  Curr Probl Surg       Date:  1988-06       Impact factor: 1.909

4.  Transplantation of multiple abdominal viscera.

Authors:  T E Starzl; M I Rowe; S Todo; R Jaffe; A Tzakis; A L Hoffman; C Esquivel; K A Porter; R Venkataramanan; L Makowka
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

5.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

6.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

7.  Malignant lymphomas in transplantation patients.

Authors:  I Penn; W Hammond; L Brettschneider; T E Starzl
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

8.  Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease.

Authors:  J W Williams; H N Sankary; P F Foster; J M Loew; G M Goldman; J Lowe
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

9.  Intestinal transplantation in composite visceral grafts or alone.

Authors:  S Todo; A G Tzakis; K Abu-Elmagd; J Reyes; K Nakamura; A Casavilla; R Selby; B M Nour; H Wright; J J Fung
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969
  9 in total
  4 in total

1.  Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation.

Authors:  J Reyes; M Green; J Bueno; N Jabbour; M Nalesnik; E Yunis; S Kocoshis; M Kauffman; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1996-10       Impact factor: 1.066

Review 2.  The future of small bowel transplantation.

Authors:  D A Kelly; J A Buckels
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

3.  Outcome analysis of 71 clinical intestinal transplantations.

Authors:  S Todo; J Reyes; H Furukawa; K Abu-Elmagd; R G Lee; A Tzakis; A S Rao; T E Starzl
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

4.  Small intestine transplantation today.

Authors:  Felix Braun; Dieter Broering; Fred Faendrich
Journal:  Langenbecks Arch Surg       Date:  2007-01-25       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.